Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of intravenous cefotaxime in children
NL-OMON34521Recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefotaxime in bacterial disease, sponsored by Canisius-Wilhelmina Hospital. Primary endpoints: Half-life of cefotaxime and desacetyl-cefotaxime, Volume of distribution at steady state and 7 more. Started Dec 2010; status: recruiting.
02
Drugs
cefotaxime
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON34521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34521.